Evidence map›Paper›PMID 34436688›Full record

ArticleAnnals of intensive care2021

Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey.

Christian Lanckohr, Christian Boeing, Jan J De Waele, Dylan W de Lange, Jeroen Schouten, Menno Prins, Maarten Nijsten, Pedro Povoa, Andrew Conway Morris, Hendrik Bracht

Open access · goldAbstract read
In one paragraph

Article in Annals of intensive care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. When to Stop Antibiotics in the Critically Ill?Antibiotics (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 5 countries.

Christian LanckohrAntibiotic Stewardship Team, Department of Hygiene, University Hospital Münster, Munster, Germany.
Christian BoeingAntibiotic Stewardship Team, Department of Hygiene, University Hospital Münster, Munster, Germany.
Jan J De WaeleDepartment of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.
Dylan W de LangeDepartment of Intensive Care Medicine, Universitair Medisch Centrum, University Utrecht, Utrecht, The Netherlands.
Jeroen SchoutenDepartment of Intensive Care, Radboud UMC, Nijmegen, The Netherlands.
Menno PrinsDept. Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
Maarten NijstenDepartment of Intensive Care Medicine, University of Groningen, Groningen, The Netherlands.
Pedro PovoaPolyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Lisbon, Portugal.
Andrew Conway MorrisDivision of Anaesthesia, University of Cambridge, Cambridge, UK.
Hendrik BrachtClinic for Anesthesiology, University Hospital Ulm, Ulm, Germany. hendrik.bracht@uniklinik-ulm.de.ORCID http://orcid.org/0000-0002-7495-7302
University Hospital Münster · DEEindhoven University of Technology · NLGhent University Hospital · BEHospital of St. Francis Xavier · PTRadboud University Nijmegen · NLUniversity Hospital Ulm · DEUniversity Medical Center Utrecht · NLUniversity of Cambridge · GBUniversity of Groningen · NL

Funding

Medical Research Council MR/V006118/1Wellcome Trust 205214/Z/16/Z
6 · The paper itself

Abstract

backgroundSevere infections and multidrug-resistant pathogens are common in critically ill patients. Antimicrobial stewardship (AMS) and therapeutic drug monitoring (TDM) are contemporary tools to optimize the use of antimicrobials. The A-TEAMICU survey was initiated to gain contemporary insights into dissemination and structure of AMS programs and TDM practices in intensive care units.

methodsThis study involved online survey of members of ESICM and six national professional intensive care societies.

resultsData of 812 respondents from mostly European high- and middle-income countries were available for analysis. 63% had AMS rounds available in their ICU, where 78% performed rounds weekly or more often. While 82% had local guidelines for treatment of infections, only 70% had cumulative antimicrobial susceptibility reports and 56% monitored the quantity of antimicrobials administered. A restriction of antimicrobials was reported by 62%. TDM of antimicrobial agents was used in 61% of ICUs, mostly glycopeptides (89%), aminoglycosides (77%), carbapenems (32%), penicillins (30%), azole antifungals (27%), cephalosporins (17%), and linezolid (16%). 76% of respondents used prolonged/continuous infusion of antimicrobials. The availability of an AMS had a significant association with the use of TDM.

conclusionsMany respondents of the survey have AMS in their ICUs. TDM of antimicrobials and optimized administration of antibiotics are broadly used among respondents. The availability of antimicrobial susceptibility reports and a surveillance of antimicrobial use should be actively sought by intensivists where unavailable. Results of this survey may inform further research and educational activities.

Indexed as

AntibioticAntimicrobial stewardshipCritical careMultiresistant bacteriaTherapeutic drug monitoring

Identifiers

PMID34436688
PMCPMC8390725
OpenAlexW3195537260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.